Nanalysis Scientific Corp.
NSCIF
$0.13
$0.016.08%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -5.67% | 5.90% | 24.66% | 57.44% | 64.79% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -5.67% | 5.90% | 24.66% | 57.44% | 64.79% |
| Cost of Revenue | -9.46% | -2.31% | 7.96% | 31.83% | 44.83% |
| Gross Profit | 6.39% | 34.39% | 99.62% | 215.40% | 193.81% |
| SG&A Expenses | -7.93% | -5.32% | -6.10% | -10.39% | -17.33% |
| Depreciation & Amortization | -14.32% | -7.73% | -6.87% | -1.78% | -7.81% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -9.31% | -3.49% | 2.49% | 14.98% | 16.20% |
| Operating Income | 36.51% | 53.16% | 73.33% | 74.56% | 63.75% |
| Income Before Tax | -64.88% | -0.39% | 17.23% | 20.85% | 63.17% |
| Income Tax Expenses | -99.37% | -100.76% | -96.20% | -6.12% | 157.87% |
| Earnings from Continuing Operations | -45.33% | 6.30% | 20.10% | 20.88% | 54.26% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -100.00% |
| Net Income | -45.33% | 6.30% | 18.89% | 18.02% | 51.60% |
| EBIT | 36.51% | 53.16% | 73.33% | 74.56% | 63.75% |
| EBITDA | -43.27% | 53.95% | 99.56% | 102.65% | 82.90% |
| EPS Basic | -36.78% | 14.36% | 27.40% | 26.73% | 55.53% |
| Normalized Basic EPS | 36.18% | 48.26% | 60.64% | 58.02% | 51.84% |
| EPS Diluted | -25.96% | 10.60% | 22.92% | 22.73% | 51.51% |
| Normalized Diluted EPS | 36.18% | 48.26% | 60.64% | 58.02% | 51.84% |
| Average Basic Shares Outstanding | 5.53% | 8.06% | 11.62% | 11.57% | 10.65% |
| Average Diluted Shares Outstanding | 5.53% | 8.06% | 11.62% | 11.57% | 10.65% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |